From ben.crossett at sydney.edu.au Wed Aug 9 18:43:23 2017 From: ben.crossett at sydney.edu.au (Ben Crossett) Date: Wed, 9 Aug 2017 08:43:23 +0000 Subject: [Metabolomics] FW: Compound Discoverer 2.1 is now installed on MSCFPP Message-ID: <91043E40EC58C34BB59CEF09BC71C18701BDF08DAE@ex-mbx-pro-04> Hi Guys, I have just upgraded our version of Compound Discovered to version 2.1. See below for the new features which come with this upgrade from version 2.0 It is available on one of the MSCFPP virtual PCs. If you don't have access and would like to give it a try drop me a line. Kind regards, Ben From: DEBRE CD Support [mailto:CD.support at thermofisher.com] Sent: Wednesday, 9 August 2017 7:25 AM To: DEBRE CD Support Subject: Compound Discoverer 2.1 is now available for download Dear Customer, The following product update is now available: Compound Discoverer 2.1 New features in version 2.1 include: - Assign Compound Annotation node automatically populates the compound name, elemental composition, and structure fields based on different sources, for example, predicted elemental composition, mzCloud, local databases, ChemSpider(tm), or BioCyc. - FISh Scoring/fragments annotation can now be calculated in batch mode on all selected chemical structures, for example, on all ChemSpider hits for an unknown compound. - mzCloud similarity search. - mzVault(tm) application to support custom spectral libraries as well as a local version of mzCloud(tm) - Improved algorithm predicts elemental composition based on fine isotopic pattern (MS1) and MS2 data - Partial Least Squares Discriminant Analysis (PLS-DA) is important for Biomarker Discovery and metabolomics. - QC-based Area Correction, a normalization method that uses pooled samples as QCs to calculate an area correction curve independently for each compound and filters compounds based on QC criteria. - Compound Class FISh Scoring node detects and scores similarities to user-defined compound classes based on common fragments - Pathway Mapping using BioCyc (beta) with support for quantitative values/statistics within the pathway ("omics overlay"). - New options to create, reset, apply, and manage custom layouts of a result display. - New export options to other Thermo Scientific(tm) applications: To download this update, log in to the Thermo Fisher Scientific Download Portal: https://protect-au.mimecast.com/s/M41aBLUQ4GVtw?domain=thermo.flexnetoperations.com If you forgot your password, use Password Finder to reset it: https://protect-au.mimecast.com/s/9OVQB5UqNLMtZ?domain=thermo.flexnetoperations.com In the TMO-Prospects account, go to Demo folder | Compound Discoverer 2.1 Demo | download Compound Discoverer 2.1 Demo.zip. The zip file includes the following instructions: 1) For Compound Discoverer 2.1 demo version (good for 60 days after license activation), use the "Instructions_CompoundDiscoverer_2_1_Demo_Flexera_July2017.docx" 2) For free upgrade from existing Compound Discoverer 2.0 full version to Compound Discoverer 2.1 full version, use the "Instructions_CompoundDiscoverer_2_1_UpgradeFrom2_0_Flexera_July2017.docx" For licensing questions or Flexera issues, contact customer support at ThermoMSLicensing at thermofisher.com. Thank you for choosing Thermo Scientific products and services. Thermo Fisher Scientific Customer Service -------------- next part -------------- An HTML attachment was scrubbed... URL: From ben.crossett at sydney.edu.au Mon Aug 14 18:32:42 2017 From: ben.crossett at sydney.edu.au (Ben Crossett) Date: Mon, 14 Aug 2017 08:32:42 +0000 Subject: [Metabolomics] =?windows-1252?q?FW=3A_Reminder=3A_Invitation_to_?= =?windows-1252?q?SCIEX_Software_Support_Webinar_=234_-_=22Matrix_effects_?= =?windows-1252?q?=96_Mass_Spec=92s_dirty_little_secret=22?= In-Reply-To: References: Message-ID: <91043E40EC58C34BB59CEF09BC71C18701BDF24C46@ex-mbx-pro-04> Hi Guys, A good one for all of you doing LCMS?find out about mass specs ?dirty little secret from Andy de Jager, Sciex?s Applications Specialist and Senior Service Engineer who will be passing on his extensive knowledge of method development for drug and small molecule assays. The webinar with cover: ? Theory on what causes matrix effects ? How to recognize matrix effects ? What can be done to minimize matrix effects ? Q&A Cheers, Ben From: Noble, Sophie [mailto:Sophie.Noble at sciex.com] Sent: Monday, 14 August 2017 12:36 PM Cc: Noble, Sophie Subject: Reminder: Invitation to SCIEX Software Support Webinar #4 - "Matrix effects ? Mass Spec?s dirty little secret" Hi All, Just a friendly reminder of our upcoming webinar session on Matrix effects ? Mass Spec?s dirty little secret. It will be delivered on Monday, 21st August 2017 at 11:30 am Australia Eastern Time (Brisbane, Melbourne GMT+10:00). Here?s how to register if you haven?t already done so: 1. Go to https://protect-au.mimecast.com/s/vxwbB0Tq6zYhZ?domain=danaher.webex.com 2. Click "Register". 3. On the registration form, enter your information and then click "Submit". Once your registration is approved, an email will be sent out to you with the WebEx details and link. Please note that the audio will be broadcast from your computer/mobile device so please ensure the volume is turned up. If you have any questions at all, please contact me directly. Looking forward to having you onboard! Regards, Sophie Sophie Noble Service Solutions Account Manager, Oceania www.sciex.com/sciexnow [better SciexNow Pic] sophie.noble at sciex.com T (AU) 1300 62 77 77 | (NZ) 0800 62 77 77 PO Box 514 Mount Waverley, VIC, 3149, Australia www.sciex.com [https://protect-au.mimecast.com/s/gn9mBLU5gJ4ur?domain=sciex.com] [https://protect-au.mimecast.com/s/oDLWBaTAY6kf6?domain=sciex.com] [https://protect-au.mimecast.com/s/AG1ZBkT9GR2hO?domain=sciex.com] [https://protect-au.mimecast.com/s/q0YwBQfxe3Etg?domain=sciex.com] [https://protect-au.mimecast.com/s/drxzBeuQ6LDhL?domain=sciex.com] [https://protect-au.mimecast.com/s/87W8BlUqkODhA?domain=sciex.com] [https://protect-au.mimecast.com/s/xMnXB1Un7DLHa?domain=sciex.com] This message may contain confidential and/or privileged information. If you are not the addressee or authorized to receive this for the addressee, you must not use, copy, disclose or take any action based on this message or any information herein. If you have received this message in error, please advise the sender immediately by reply e-mail and delete this message. Thank you for your cooperation. Please be advised that this email may contain confidential information. If you are not the intended recipient, please notify us by email by replying to the sender and delete this message. The sender disclaims that the content of this email constitutes an offer to enter into, or the acceptance of, any agreement; provided that the foregoing does not invalidate the binding effect of any digital or other electronic reproduction of a manual signature that is included in any attachment. -------------- next part -------------- An HTML attachment was scrubbed... URL: -------------- next part -------------- A non-text attachment was scrubbed... Name: image009.jpg Type: image/jpeg Size: 10212 bytes Desc: image009.jpg URL: -------------- next part -------------- A non-text attachment was scrubbed... Name: image010.jpg Type: image/jpeg Size: 4317 bytes Desc: image010.jpg URL: -------------- next part -------------- A non-text attachment was scrubbed... Name: image011.jpg Type: image/jpeg Size: 745 bytes Desc: image011.jpg URL: -------------- next part -------------- A non-text attachment was scrubbed... Name: image012.png Type: image/png Size: 1600 bytes Desc: image012.png URL: -------------- next part -------------- A non-text attachment was scrubbed... Name: image013.png Type: image/png Size: 1397 bytes Desc: image013.png URL: -------------- next part -------------- A non-text attachment was scrubbed... Name: image014.jpg Type: image/jpeg Size: 871 bytes Desc: image014.jpg URL: -------------- next part -------------- A non-text attachment was scrubbed... Name: image015.jpg Type: image/jpeg Size: 918 bytes Desc: image015.jpg URL: -------------- next part -------------- A non-text attachment was scrubbed... Name: image016.png Type: image/png Size: 5831 bytes Desc: image016.png URL: From ben.crossett at sydney.edu.au Mon Aug 21 12:43:56 2017 From: ben.crossett at sydney.edu.au (Ben Crossett) Date: Mon, 21 Aug 2017 02:43:56 +0000 Subject: [Metabolomics] Metabolomics talks on Tuesday Message-ID: <91043E40EC58C34BB59CEF09BC71C18701BDF403AC@ex-mbx-pro-04> Hi Folks, We have a couple of metabolomics talks tomorrow: From: Alison Macgregor On Behalf Of Charles Perkins Centre Sent: Monday, 21 August 2017 11:19 AM To: Charles Perkins Centre Subject: What's on this week: 21 - 25 August Tuesday 22 August Time 12-1pm Venue Centenary Institute Lecture Theatre, Level 6 Event Centenary Institute Seminar Series Speaker Dr John O'Sullivan About Probing Cardiometabolic Disease (flyer attached) Tuesday 22 August Time 2-3pm Venue Level 6 Seminar room Event Visiting Scholar Seminar Speaker Professor Haitao Lu About Metabolomics facilitated the characterization of functional small molecules towards a diversity of biological innovations -------------- next part -------------- An HTML attachment was scrubbed... URL: -------------- next part -------------- A non-text attachment was scrubbed... Name: 22 08 17 OSullivan.pdf Type: application/pdf Size: 332331 bytes Desc: 22 08 17 OSullivan.pdf URL: From ben.crossett at sydney.edu.au Wed Aug 23 08:54:45 2017 From: ben.crossett at sydney.edu.au (Ben Crossett) Date: Tue, 22 Aug 2017 22:54:45 +0000 Subject: [Metabolomics] Darren Creek - Centenary Institute Tuesday Seminar August 29th Message-ID: <91043E40EC58C34BB59CEF09BC71C18701BDF41ACA@ex-mbx-pro-04> Hi Folks, Like busses, you wait ages and then three turn up at once! Next Tuesday we have another metabolomics talk: 12.00pm to 1.00pm Tuesday 29th August, 2017 Dr Darren Creek Senior Lecturer, (Career Development Fellow) Monash Institute of Pharmaceutical Sciences "Discovering Mechanisms of Drug Action and Resistance with Metabolomics" The Centenary Institute Lecture Theatre, Level 6, Building 93, Royal Prince Alfred Hospital Grounds Lunch will be provided for attendees following the seminar. Darren will be around most of the day, if you would like to meet up with him contact: Anthony Don [mailto:a.don at centenary.org.au] About the speaker: Dr Darren Creek is a Senior Lecturer, NHMRC Career Development Fellow and head of the pharmaceutical metabolomics laboratory at the Monash Institute of Pharmaceutical Sciences. He completed his PhD at Monash University in 2007, and performed post-doctoral research in Uganda, Scotland and Australia working on antimalarial drug discovery and clinical trials, before focusing on metabolomics studies of tropical parasites.He developed several novel analytical methods and software tools for the metabolomics eld, and discovered novel pathways and drug mechanisms in protozoan parasites. Dr Creek?s laboratory currently uses metabolomics and proteomics to understand mechanisms of drug action and resistance for cancer and infectious diseases, with a major focus on African trypanosomiasis and malaria. Darren continues to develop novel metabolomics methods to advance the eld and is a Director of the international Metabolomics Society. About the seminar: Drug resistance poses a major threat to the management of infectious diseases, and new drugs are urgently required for many common infections.Unfortunately, the development of new drugs is often hampered by a lack of knowledge regarding the mechanisms of action and resistance of existing drugs,and of new lead compounds. Recent advances in post-genomic technologies, including metabolomics and proteomics, provide an opportunity for unbiased analysis of the impact of drug treatment on cellular biochemistry, allowing discovery of previously unanticipated mechanisms of drug action and resistance. We have used these technologies to discover the mode of action of over 100 compounds that target the causative agents of malaria and African trypanosomiasis. Furthermore, multi-omic analysis of malaria parasites resistant to the rst-, and last-line antimalarials, the artemisinins, revealed depleted levels of a key biomarker protein, and differential regulation of haemoglobin digestion and glutathione synthesis. These ndings provide opportunities for clinical translation of new biomarkers of drug resistance, and provide direct evidence of the resistance mechanisms which may be exploited to enhance the activity of these important medicines. -------------- next part -------------- An HTML attachment was scrubbed... URL: